PACIFIC: Overall survival with durvalumab versus placebo after chemoradiotherapy in stage III NSCLC
Raben, D Spigel, D Daniel, D Villegas, A Vincente, D Hui, R Carpeno, J Murakami, S Paz-Ares, L
Raben, D
Spigel, D
Daniel, D
Villegas, A
Vincente, D
Hui, R
Carpeno, J
Murakami, S
Paz-Ares, L
Citations
Altmetric:
Abstract
Affiliation
Description
Date
2018
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Raben D, Faivre-Finn C, Spigel D, Daniel D, Villegas A, Vincente D, et al. PACIFIC: Overall survival with durvalumab versus placebo after chemoradiotherapy in stage III NSCLC. Int J Radiat Oncol Biol Phys. 2018;102(5):1607-8.